NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. |
|
|
| Withdrawn | 1b | 0 | US | Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib | Pfizer | Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular | 11/13 | 11/13 | | |
NCT03275558: Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma |
|
|
| Withdrawn | 1 | 0 | RoW | Axitinib 1 MG, AG 013736, Inlyta, Sunitinib 5 MG, SU11248, Sutent, Pazopanib 5 MG, GW786034, Votrient | Center Trials & Treatment | Recurrent Glioblastoma, Gliosarcoma, Anaplastic Gliomas | 07/18 | 07/18 | | |
